Unknown

Dataset Information

0

Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors.


ABSTRACT: Aberrant promoter DNA hypermethylation is a hallmark of cancer; however, whether this is sufficient to drive cellular transformation is not clear. To investigate this question, we use a CRISPR-dCas9 epigenetic editing tool, where an inactive form of Cas9 is fused to DNA methyltransferase effectors. Using this system, here we show simultaneous de novo DNA methylation of genes commonly methylated in cancer, CDKN2A, RASSF1, HIC1 and PTEN in primary breast cells isolated from healthy human breast tissue. We find that promoter methylation is maintained in this system, even in the absence of the fusion construct, and this prevents cells from engaging senescence arrest. Our data show that the key driver of this phenotype is repression of CDKN2A transcript p16 where myoepithelial cells harbour cancer-like gene expression but do not exhibit anchorage-independent growth. This work demonstrates that hit-and-run epigenetic events can prevent senescence entry, which may facilitate tumour initiation.

SUBMITTER: Saunderson EA 

PROVIDER: S-EPMC5684409 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors.

Saunderson Emily A EA   Stepper Peter P   Gomm Jennifer J JJ   Hoa Lily L   Morgan Adrienne A   Allen Michael D MD   Jones J Louise JL   Gribben John G JG   Jurkowski Tomasz P TP   Ficz Gabriella G  

Nature communications 20171113 1


Aberrant promoter DNA hypermethylation is a hallmark of cancer; however, whether this is sufficient to drive cellular transformation is not clear. To investigate this question, we use a CRISPR-dCas9 epigenetic editing tool, where an inactive form of Cas9 is fused to DNA methyltransferase effectors. Using this system, here we show simultaneous de novo DNA methylation of genes commonly methylated in cancer, CDKN2A, RASSF1, HIC1 and PTEN in primary breast cells isolated from healthy human breast ti  ...[more]

Similar Datasets

2017-08-07 | GSE100209 | GEO
2017-08-07 | GSE100184 | GEO
2017-08-07 | GSE100027 | GEO
2017-08-07 | GSE100208 | GEO
| PRJNA390993 | ENA
| S-EPMC5039111 | biostudies-literature
2016-08-26 | GSE81826 | GEO
| S-EPMC4738784 | biostudies-other
| S-EPMC6753487 | biostudies-literature
| S-EPMC7430633 | biostudies-literature